By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Stemline Therapeutics, Inc. 

1675 York Avenue
Suite 30-E
New York  New York  10128  U.S.A.
Phone: 212-831-1111 Fax:


SEARCH JOBS








Company News
Stemline Therapeutics, Inc. (STML) To Present At The Cowen and Company 36th Annual Health Care Conference 3/3/2016 8:26:39 AM
Stemline Therapeutics, Inc. (STML) To Present At The 18th Annual BIO CEO & Investor Conference 2/4/2016 7:54:50 AM
Stemline Therapeutics, Inc. (STML) To Present At The 34th Annual J.P. Morgan Healthcare Conference 1/5/2016 8:29:53 AM
Stemline Therapeutics, Inc. (STML) Presents Clinical Update From Ongoing SL-401 Pivotal BPDCN Trial At The American Society of Hematology Annual Meeting 12/8/2015 11:26:08 AM
Stemline Therapeutics, Inc. (STML) Announces Five Presentations, Including SL-401 Clinical Update From Ongoing Pivotal BPDCN Trial, At The Upcoming American Society of Hematology Annual Meeting 12/4/2015 7:46:46 AM
Stemline Therapeutics, Inc. (STML) To Present At The Oppenheimer 26th Annual Healthcare Conference 12/3/2015 8:48:35 AM
Stemline Therapeutics, Inc. (STML) Reports Third Quarter 2015 Financial Results 11/6/2015 7:08:21 AM
Stemline Therapeutics, Inc. (STML) Announces Five Presentations At The American Society of Hematology Annual Meeting; SL-401 Poster Will Include Clinical Data From Lead-In And Ongoing Expansion Stages Of BPDCN Pivotal Trial 11/5/2015 8:32:35 AM
Stemline Therapeutics, Inc. (STML) Announces SL-401 Receives EU Orphan Drug Designation For Treatment Of BPDCN 11/2/2015 7:45:11 AM
Stemline Therapeutics, Inc. (STML) To Present At The Ladenburg Thalmann 2015 Healthcare Conference 9/29/2015 7:02:32 AM
12345678910
//-->